As coronavirus continues to spread, older adults face a challenge: how to get the medications they need without putting themselves at risk. A new national survey shows they aren’t prepared.
A lot of numbers are being tossed around about COVID-19 and what to expect in the future. They’re being used to make critical public health decisions, but they aren’t as simple as they appear.
Asthma rescue inhalers are in short supply, and asthma sufferers are worried about the risks they face from COVID-19. A doctor answers six key questions.
U.S. health officials flipped their advice and now recommend everyone wear cloth masks in public to reduce the spread of coronavirus to others. Some cities have fines for going without masks.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
A molecular biologist explains who should get tested, how the tests work and what the US government is doing to make tests available during a rapidly changing crisis.
From the neighborhood to the newsroom to the White House, nobody stays silent during a health emergency. These terms are often mixed up, and it matters who is using them and when.
In a health crisis, decisions about treatment and containment must be made quickly. It’s crucial those decisions be based on research evidence, but fast and easy access is not always available.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Professor of Civil, Environmental & Ecological Engineering, Director of the Healthy Plumbing Consortium and Center for Plumbing Safety, Purdue University